companydata.dkInxo A/S: Financial statements 2021
CVR: 37758272
Inxo A/S (CVR 37758272) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,309,882 and a net result of DKK -1,941,185 compared with DKK -174,248 the year before. Equity amounted to DKK 1,379,730. The solvency ratio was 34.7%.
- Gross Profit
- -1,309,882 kr.
- Profit/Loss
- -1,941,185 kr.
- Equity
- 1,379,730 kr.
- Total Assets
- 3,979,623 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -1.3 mio. | -1.9 mio. | 1.4 mio. | - |
| 2020 | - | -215 t. | -174 t. | 321 t. | - |
| 2019 | - | 0 | -63 | 95 t. | 1 |
| 2018 | - | -900 | -936 | -5 t. | 1 |
| 2017 | - | -800 | -665 | -4 t. | - |
Find more companies like Inxo A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 7, 2021, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Inxo A/S.
As of December 7, 2021, Cathrine Werthwein Andersen has joined the board of directors of Inxo A/S.
Inxo A/S has published its annual report for 2020. Gross profit came to DKK -214,644, and the net result was DKK -174,248.
As of January 1, 2021, Pouline Charlotte Friderichsen Middleton is registered as adm. dir. of Inxo A/S.
About Inxo A/S
Inxo A/S was a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2016. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company's owners include SPINAL ApS, MEVA HOLDING ApS and Niox Holding ApS. In 2024, the company reported a gross profit of DKK -430,563 and a net result of DKK -737,722 compared with DKK -2,834,092 the year before. Equity amounted to DKK -3,245,500.